Prof. ZEYNEP ŞAFAK TEKSİN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation

Yılmaz Usta D., Teksin Z. Ş., Tuğcu Demiröz F. N.

AAPS PHARMSCITECH , vol.25, pp.1-15, 2024 (SCI-Expanded) Sustainable Development

Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging

Yılmaz Usta D., Olgac S., Tımur B., Teksin Z. Ş.

International Journal of Pharmaceutics , vol.643, 2023 (SCI-Expanded) Sustainable Development

Evaluation of The Effects of Carob<i> (Ceratonia</i><i> siliqua</i> L.) Fruits on the Puberty of Rats

Kılınç Uğurlu A., Bideci A., Anadol E., Süntar İ., Take Kaplanoğlu G., Gülbahar Ö., et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , vol.15, no.2, pp.145-153, 2023 (SCI-Expanded)

QbD Application for a Fixed-Dose Combination with Biowaiver Potential: Evaluations of In Vitro and In Vivo Applications

Sarisaltik-Yasin D., Uslu A., UYAR E., ERDİNÇ M., TEKSİN Z. Ş.

JOURNAL OF PHARMACEUTICAL INNOVATION , vol.18, no.1, pp.164-181, 2023 (SCI-Expanded)

Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model

Timur B., Yılmaz Usta D., Teksin Z. S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.77, 2022 (SCI-Expanded)

Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment

Usta D., Timur B., TEKSİN Z. Ş.

European Journal of Pharmaceutical Sciences , vol.174, 2022 (SCI-Expanded)

Role of Surfactants on Dissolution Behavior of Tamoxifen

İNCEÇAYIR T., Olgac S., Usta D. Y., TEKSİN Z. Ş.

DISSOLUTION TECHNOLOGIES , vol.28, no.2, 2021 (SCI-Expanded)

Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation

Erdogar N., NEMUTLU E., Iskit A. B., Kara S. C., TEKSİN Z. Ş., BİLENSOY E.

JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.96, pp.81-91, 2020 (SCI-Expanded)

Evaluation of improved oral bioavailability of ritonavir nanosuspension

Karakucuk A., TEKSİN Z. Ş., EROĞLU H., Celebi N.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.131, pp.153-158, 2019 (SCI-Expanded)

Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach

Karakucuk A., Celebi N., Teksin Z. Ş.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.95, pp.111-121, 2016 (SCI-Expanded) Sustainable Development

BIOWAIVER APPROACH FOR BCS: DISCUSSION OF BIOWAVER MONOGRAPHS FOR IMMEDIATE-RELEASE SOLID ORAL DOSAGE FORMS

TEKSİN Z. Ş.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.50, 2013 (SCI-Expanded)

IMPLEMENTATION OF BCS BASED BIOWAIVER IN TURKEY

TORT S., Koksal H. T., TEKSİN Z. Ş.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.50, 2013 (SCI-Expanded)

Comparison of Drug Permeabilities and BCS Classification: Three Lipid-Component PAMPA System Method versus Caco-2 Monolayers

Teksin Z. Ş., Seo P. R., Polli J. E.

AAPS JOURNAL , vol.12, no.2, pp.238-241, 2010 (SCI-Expanded)

Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen

Teksin Z. Ş., Lee I. J., Nemieboka N. N., Othman A. A., Upreti V. V., Hassan H. E., et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.72, no.2, pp.471-477, 2009 (SCI-Expanded)

Lipid composition effect on permeability across PAMPA

Seo P. R., Teksin Z. Ş., Kao J. P. Y., Polli J. E.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.29, pp.259-268, 2006 (SCI-Expanded)

Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system

Teksin Z. Ş., Hom K., Balakrishnan A., Polli J. E.

JOURNAL OF CONTROLLED RELEASE , vol.116, no.1, pp.50-57, 2006 (SCI-Expanded)

Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation

Yamac K., Kaptan K., Beyan C., Teksin Z. Ş., Agabeyoglu I., Gokgoz L.

ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, pp.827-831, 2000 (SCI-Expanded)

Articles Published in Other Journals

Lipit Temelli Taşıyıcı Sistemler-II: Katı Kendiliğinden Emülsifiye İlaç Taşıyıcı Sistem Formülasyonlarına Bakış: Geleneksel Derleme

Yılmaz Usta D., Teksin Z. Ş.

Literatür Eczacılık Bilimleri Dergisi , vol.14, no.1, pp.1-9, 2025 (Peer-Reviewed Journal) Sustainable Development

Preliminary Study on the Development of Orodispersible Film Containing Desloratadine

Çakmakyapan Ö., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.

Turkish Journal of Pharmaceutical Sciences , vol.22, no.1, pp.55-63, 2025 (ESCI)

Bitkisel İlaçların Farmakokinetik-Biyoyararlanım Değerlendirmeleri ve Ruhsat Aşamaları: Geleneksel Derleme

TİMUR B., TEKSİN Z. Ş.

Literatür Eczacılık Bilimleri Dergisi , vol.11, no.1, pp.61-76, 2022 (Peer-Reviewed Journal)

Development and validation of an HPLC method using an experimental design for analysis of amlodipine besylate and enalapril maleate in a fixed dose combination

Sarısaltık Yaşın D., Arslantürk Bingül A., Karaküçük A. E., Teksin Z. Ş.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.18, no.3, pp.306-318, 2021 (ESCI)

Biopharmaceutics, Pharmacokinetics and Patent Evaluations of Drugs Used in the Treatment of COVID-19: Current Status in the Development of Generic Drugs in Turkey

YILMAZ USTA D., TEKSİN Z. Ş.

GAZI MEDICAL JOURNAL , vol.31, pp.498-509, 2020 (ESCI) Sustainable Development

Evaluation of biorelevant media to investigate the dissolution properties on flurbiprofen and to assess cytotoxicity effects on Caco-2 cell line

Yasin D. S., Yilmaz S., TEKSİN Z. Ş.

ISTANBUL JOURNAL OF PHARMACY , vol.48, no.3, pp.82-88, 2018 (ESCI)

Biopharmaceutics Classification System: Evaluation on International Guidelines and Countries

SARISALTIK YAŞIN D., TEKSİN Z. Ş.

Journal of Literature Pharmacy Sciences , vol.7, no.2, pp.160-174, 2018 (Peer-Reviewed Journal)

Evaluation of in vitro Dissolution Characteristics of Flurbiprofen, a BCS Class IIa Drug

YILMAZ USTA D., demirtaş ö., ökçelik c., uslu a., TEKSİN Z. Ş.

FABAD J. Pharm. Sci , vol.43, no.2, pp.27-34, 2018 (Peer-Reviewed Journal)

Açlık ve Tokluk Durumlarını Taklit Eden Biyouyumlu Çözünme Ortamlarının Değerlendirilmesi

SARISALTIK YAŞIN D., TEKSİN Z. Ş.

FABAD J.Pharm.Sci , vol.48, no.3, pp.217-232, 2018 (Peer-Reviewed Journal) Sustainable Development

İn Vitro Çözünme Hızı Çalışmalarında Yeni Yaklaşımlar

YILMAZ USTA D., TEKSİN Z. Ş.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.40, no.1, pp.33-40, 2017 (Scopus)

Biyoeşdeğerlik Çalışmalarından Vazgeçilmesinde Biyofarmasötik İlaç Sınıflandırma Sistemlerinin Değerlendirilmesi Biyofarmasötik Sınıflandırma Sistemi BCS ve Biyofarmasötik İlaç Dağılım Sınıflandırma Sistemi BDDCS

SARISALTIK YAŞIN D., TEKSİN Z. Ş.

Türkiye Klinikleri Eczacılık Bilimleri Dergisi, , vol.1, no.1, pp.16-30, 2011 (Peer-Reviewed Journal)

Bioavailability of Pentoxifylline Chitosan Oral Matrix Tablet in Healthy Subjects

AĞABEYOĞLU T. İ., YAMAC K., TEKSİN Z. Ş.

J. Bioequivalence & Bioavailability , vol.1, no.4, pp.115-120, 2009 (Peer-Reviewed Journal)

Bioavailability File: Levofloxacin

SARISALTIK YAŞIN D., TEKSİN Z. Ş.

FABAD J.Pharm.Sci , vol.32, no.4, pp.197-208, 2007 (Scopus)

Biyoeşdeğerlik çalışmalarından vazgeçme kriterlerinde yeni yaklaşımlar

TEKSİN Z. Ş.

TÜFTAD , vol.9, no.4, pp.9-11, 2002 (Non Peer-Reviewed Journal)

Solubility of Resin Based Restorative Materials in Different pH Values

KARACAER Ö., YAMAN S., TEKSİN Z. Ş.

J.Gazi Univ.Fac.Dent. , vol.19, no.1, pp.1-4, 2002 (Peer-Reviewed Journal)

Kronofarmakokinetiğin önemi ve kronofarmasötik ilaç şekli tasarımı

TEKSİN Z. Ş., ABACIOĞLU N.

TÜFTAD , vol.9, no.3, pp.3-4, 2002 (Non Peer-Reviewed Journal)

Papers Published in Refereed Scientific Meetings

Assessment of in vitro release and in vitro lipolysis for interleukin-2-loaded double self-nanoemulsifying drug delivery system

OLĞAÇ S., TİMUR B., TEKSİN Z. Ş.

JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Austria, 19 - 21 February 2025

In vitro performance of Exemestan-loaded SNEDDS formulations: Dissolution in biorelevant media and antiproliferative activity on MCF-7 cell line

TİMUR B., VARAN G., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.

JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Austria, 19 - 21 February 2025

Exploring Protease Enzyme Selection for Protein-Structured Active Ingredient Loaded Drug Formulation with Molecular Dynamics Simulations

OLĞAÇ S., OLĞAÇ A., TEKSİN Z. Ş.

21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024

Evaluation of EXE-loaded SNEDDS using simultaneous lipolysis/ex-vivo permeability and lipolysis/in situ single-pass intestinal perfusion method

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.

21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024 Sustainable Development

Development of Recombinant Human Interleukin-2 Loaded Double Nanoemulsions Using Microfluidizer® for Oral Drug Delivery

OLĞAÇ S., TEKSİN Z. Ş.

21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024

Histology and pharmacodynamic echocardiography studies of bosentan-loaded SNEDDS and S-SNEDDS: New oral drug delivery systems for pulmonary arterial hypertension

Yılmaz Usta D., Olğaç S., Demirel M. A., Kula S., Kavgacı A., Sezginer P., et al.

EUFEPS Annual Meeting 2023, Lizbon, Portugal, 31 May - 02 June 2023, pp.165

Screening and assessment of excipients for nanoemulsion formulationsof interleukin-2 with computational studies

Olğaç S., Olğaç A., Teksin Z. Ş.

EUFEPS Annual Meeting 2023, Lisbon, Portugal, 31 May - 02 June 2023

Assessment of in vitro digestion for exemestane-loaded lipid-based formulations

Timur B., Yılmaz Usta D., Teksin Z. Ş.

FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Netherlands, 1 - 03 June 2022, pp.45-46 Sustainable Development

Evaluation of pharmacokinetic and pharmacodynamic real-time biodistribution of bosentan formulations

Yılmaz Usta D., Teksin Z. Ş.

FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Netherlands, 1 - 03 June 2022, pp.47 Sustainable Development

Bioequivalence and interchangeability issues in Modified Release Dosage Forms

TEKSİN Z. Ş.

20th International Pharmaceutical Technology Symposium, 21 February 2022

DEVELOPMENT AND VALIDATED OF UV SPECTROPHOTOMETRIC AND HPLC METHOD OF BOSENTAN MONOHYDRATE FOR IN VITRO AND EX-VIVO SAMPLES

Yılmaz Usta D., Olgac S., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.33

SOLID-STATE CHARACTERIZATION STUDIES OF BOSENTAN-LOADED SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS) COMPRISING OF NEUSILIN® US2

Yılmaz Usta D., Olgac S., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.36

DEVELOPMENT OF IN VITRO LIPOLYSIS-PERMEATION METHOD TO ESTIMATE ORAL ABSORPTION OF EXEMESTANE-LOADED LIPID-BASED FORMULATION

Timur B., Yılmaz Usta D., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.30

IN VITRO CHARACTERIZATION OF EXEMESTANE-LOADED SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM CONTAINING MEDIUM CHAIN MONO AND DIGLYCERIDES

Timur B., Yılmaz Usta D., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.37

Structure-Guided Selection of Suitable Nanoemulsion Formulation Components for a Recombinant Form of Human Interleukin-2 (Aldesleukin)

Olğaç S., Olğaç A., İnceçayır T., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021

MODELING AND COMPARISON OF IN VITRO DISSOLUTION PROFILES OF BOSENTAN MONOHYDRATE: COMMERCIAL TABLET VS S-SNEDDS TABLET

Yılmaz Usta D., Teksin Z. Ş.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.35

Assessment The Correlation Between In Vitro Dissolution and In Vitro Intestinal Lipolysis Data for Bosentan Loaded Lipid-Based Formulations

TİMUR B., YILMAZ USTA D., TEKSİN Z. Ş.

Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021

Evaluation of Ex-vivo Permeability and In Vitro Dissolution of BOS-loaded S-SNEDDS Tablets

YILMAZ USTA D., TEKSİN Z. Ş.

Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021

Evaluation of Bosentan-Loaded Self-nanoemulsifying Drug Delivery Systems Containing Peceol

YILMAZ USTA D., TEKSİN Z. Ş.

Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021